Literature DB >> 28939019

Anti-inflammatory effects of traditional mixed extract of medicinal herbs (MEMH) on monosodium urate crystal-induced gouty arthritis.

Ju-Suk Nam1, Supriya Jagga1, Ashish Ranjan Sharma1, Joon-Hee Lee2, Jong Bong Park1, Jun-Sub Jung3, Sang-Soo Lee4.   

Abstract

Korean oriental medicine prescription is widely used for the treatment of gouty diseases. In the present study, we investigated anti-inflammatory effects of modified Korean herbal formulation, mixed extract of medicinal herbs (MEMH), and its modulatory effects on inflammatory mediators associated with gouty arthritis. Both in vitro and in vivo studies were carried out to assess the anti-inflammatory efficacy of MEMH on monosodium urate (MSU) crystals-induced gouty inflammation. MSU crystals stimulated human chondrosarcoma cell line, SW1353, and human primary chondrocytes were treated with MEMH in vitro. The expression levels of pro-inflammatory mediators and metalloproteases were analyzed. The effect of MEMH on NFκB signaling pathway in SW1353 cells was examined. Effect of MEMH on the mRNA expression level of pro-inflammatory mediators and chemotactic factor from human monocytic cell line, THP-1, was also analyzed. The probable role of MEMH in the differentiation process of osteoblast like cells, SaOS-2, after MSU treatment was also observed. To investigate the effects of MEMH in vivo, MSU crystals-induced ankle arthritic model was established. Histopathological changes in affected joints and plasma levels of pro-inflammatory mediators (IL-1β and TNFα) were recorded. MEMH inhibited NFκB signaling pathway and COX-2 protein expression in chondrocytes. MSU-induced mRNA expressions of pro-inflammatory mediators and chemotactic cytokines were suppressed by MEMH. In MSU crystals-induced ankle arthritic mouse model, administration of MEMH relieved inflammatory symptoms and decreased the plasma levels of IL-1β and TNFα. The results indicated that MEMH can effectively inhibit the expression of inflammatory mediators in gouty arthritis, demonstrating its potential for treating gouty arthritis.
Copyright © 2017 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chondrocyte; Gout; Inflammation; Monosodium urate crystals; Oriental medicine

Mesh:

Substances:

Year:  2017        PMID: 28939019     DOI: 10.1016/S1875-5364(17)30084-5

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  5 in total

1.  The potential role of herbal extract Wedelolactone for treating particle-induced osteolysis: an in vivo study.

Authors:  Yung-Chang Lu; Ting-Kuo Chang; Tzu-Chiao Lin; Shu-Ting Yeh; Hsu-Wei Fang; Chun-Hsiung Huang; Chang-Hung Huang
Journal:  J Orthop Surg Res       Date:  2022-06-28       Impact factor: 2.677

2.  Differential Expression Patterns of Rspondin Family and Leucine-Rich Repeat-Containing G-Protein Coupled Receptors in Chondrocytes and Osteoblasts.

Authors:  Yeon Hee Lee; Ashish Ranjan Sharma; Supriya Jagga; Sang Soo Lee; Ju Suk Nam
Journal:  Cell J       Date:  2020-04-22       Impact factor: 2.479

3.  Zisheng Shenqi Decoction Ameliorates Monosodium Urate-Mediated Gouty Arthritis in Rats via Promotion of Autophagy through the AMPK/mTOR Signaling Pathway.

Authors:  Jieru Han; Guangyu Shi; Wenhao Li; Shuhui Wang; Jixiang Bai; Xutao Sun; Ying Xie; Fangyu Sui; Fei Chen; Deyou Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-06       Impact factor: 2.629

4.  Preventive effect of dioscin against monosodium urate-mediated gouty arthritis through inhibiting inflammasome NLRP3 and TLR4/NF-κB signaling pathway activation: an in vivo and in vitro study.

Authors:  Jieru Han; Guangyu Shi; Wenhao Li; Ying Xie; Fuzhen Li; Deyou Jiang
Journal:  J Nat Med       Date:  2020-08-06       Impact factor: 2.343

5.  Sclerostin-Mediated Impaired Osteogenesis by Fibroblast-Like Synoviocytes in the Particle-Induced Osteolysis Model.

Authors:  Supriya Jagga; Ashish Ranjan Sharma; Yeon Hee Lee; Ju-Suk Nam; Sang-Soo Lee
Journal:  Front Mol Biosci       Date:  2021-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.